Work is ongoing in the following areas:
- Development of nanoparticle based immunotherapies for tuberculosis
- Development of inhalable drug loaded microparticles for treatment of tuberculosis
- Studies of the interaction of nanoparticles and the biological environment
- Synthesis of nanoparticles for drug delivery across complex biological barriers